Adjei, Alex A <br/><br/>
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.  [electronic resource] 

 -  Investigational new drugs  Aug 2002 
 - 297-304 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1023/a:1016237426846  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acridines--administration & dosage<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Area Under Curve<br/>Carboplatin--administration & dosage<br/>DNA Adducts--metabolism<br/>Drug Interactions<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Neutropenia--chemically induced<br/>Platinum--metabolism<br/>Pyrazoles--administration & dosage